GENinCode (LON:GENI) Trading Down 11.6% – Should You Sell?

GENinCode Plc (LON:GENI) shares dropped 11.6% during trading on Thursday . The stock traded as low as GBX 1.10 and last traded at GBX 1.11. Approximately 6,105,473 shares were traded during trading, a decline of 0% from the average daily volume of 6,128,636 shares. The stock had previously closed at GBX 1.25.

GENinCode Stock Performance

The company has a market cap of £8.37 million, a price-to-earnings ratio of -0.49 and a beta of 0.61. The firm has a 50-day simple moving average of GBX 1.13 and a 200 day simple moving average of GBX 1.57. The company has a quick ratio of 15.89, a current ratio of 2.80 and a debt-to-equity ratio of 7.17.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.